<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153117">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02014090</url>
  </required_header>
  <id_info>
    <org_study_id>177/07</org_study_id>
    <nct_id>NCT02014090</nct_id>
  </id_info>
  <brief_title>Acute Hemodynamic and Biological Effects of ECP and Exercise</brief_title>
  <official_title>Acute Cardiovascular Effects of External Counterpulsation (ECP) in Comparison With Physical Exercise in Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study in humans with stable coronary artery disease (CAD) treatable by
      percutaneous intervention (PCI) is to evaluate the efficacy of Enhanced External
      Counterpulsation (EECP) with regard to coronary collateral growth.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Myocardial Blood Flow (MBF) measurement by Myocardial Contrast Echocardiography (MCE)</measure>
    <time_frame>During ECP respectively Bicycle Exercise, expected to be on average 90 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Puls Wave Velocity Analysis</measure>
    <time_frame>At baseline &amp; post intervention, expected to be on average 90 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Patients With Stable Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>half supine bicycle Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>60 minutes of half supine bicycle exercise with submaximal workload</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ECP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>90 minutes of ECP</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hemodynamic and biological measurements</intervention_name>
    <description>by MCE, PWA, Doppler, Multiplex, FACS</description>
    <arm_group_label>half supine bicycle Exercise</arm_group_label>
    <arm_group_label>ECP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years, written informed consent to participate in the study

        Exclusion Criteria:

          -  1. Pregnancy (serum Î²-HCG&lt;2 IU/l for all female volunteers)

        Baseline History:

          1. Endurance exercise 5 days before and the days between the exams

          2. History of cardiovascular disease or surgery, including arterial hypertension,
             Raynaud phenomenon, recurrent migraine, or any cardiac rhythm disorder

          3. History of metabolic disorder, particularly diabetes mellitus

          4. History of respiratory, renal, hepatic or cerebral disease

          5. Allergic reactions to Luminity or its components

          6. Cardiovascular medication

          7. Illness characterized by acute phase response

          8. Anaemia with haemoglobin levels &lt; 110 g/L

        Baseline Physical Examination:

        1. Peripheral artery disease

        Baseline Echocardiogram:

          1. Valvular heart disease

          2. Aortic aneurysm (any abnormality of ascending aorta, aortic arch or descending aorta)

          3. Intra- or extracardiac shunt

          4. Systolic or diastolic left ventricular (LV) dysfunction

          5. LV-hypertrophy

          6. Pulmonary arterial hypertension
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steffen Gloekler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefano de Marchi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefano Rimoldi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Seiler, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 11, 2013</lastchanged_date>
  <firstreceived_date>April 5, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Inselspital, Berne</investigator_affiliation>
    <investigator_full_name>Christian Seiler</investigator_full_name>
    <investigator_title>Prof Dr med</investigator_title>
  </responsible_party>
  <keyword>ECP</keyword>
  <keyword>Endurance exercise</keyword>
  <keyword>myocardial perfusion</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
